Resolving crossmatch incompatibility due to daratumumab in multiple myeloma

Resolving crossmatch incompatibility due to daratumumab in multiple myeloma

Daratumumab (DARA) is an anti-CD38 monoclonal antibody which has promising results in relapsed and refractory multiple myeloma. DARA interferes with blood compatibility testing by causing panagglutination in the indirect antiglobulin test. In all incompatibilities, immunohematology workup must be do...

Full description

Bibliographic Details
Main Authors: S Anuragaa, Dibyajyoti Sahoo, B Abhishekh
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Global Journal of Transfusion Medicine
Subjects:
daratumumab
dithiothreitol
incompatibility
Online Access:http://www.gjtmonline.com/article.asp?issn=2468-8398;year=2020;volume=5;issue=2;spage=225;epage=227;aulast=Anuragaa

Similar Items

Similar Items